Second-Generation ALK Inhibitors in Non-Small Cell Lung Cancer March 27, 2014[email protected] In this segment, panelists discuss the promising activity demonstrated by three novel second-generation ALK inhibitors for patients with ALK-positive non-small cell lung cancer.
